In humans with CHF, hyperglycemia (defined as 144–180 mg/dL) is common due to impaired insulin mediated glucose uptake and cytokine mediated suppression of insulin release and has been shown to be a negative prognostic indicator (15, 16). This evidence concerns the gene INS and Hyperglycemia.